PP
CLVS

Paloma Partners’s Clovis Oncology, Inc. CLVS Stock Holding History

Paloma Partners’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-20,336
Closed -$55K – 2409
2021
Q4 		$55K Buy
+20,336
New +$75.2K ﹤0.01% 1824
2017
Q3 		– Sell
-4,800
Closed -$381K – 2549
2017
Q2 		$449K Buy
+4,800
New +$294K 0.01% 1608
2014
Q3 		– Sell
-35,000
Closed -$1.45M – 1371
2014
Q2 		$1.45M Buy
35,000
+10,000
+40% +$515K 0.06% 279
2014
Q1 		$1.73M Buy
+25,000
New +$1.84M 0.11% 166

Other funds holding CLVS

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Paloma Partners's CLVS Position: Q1 2022 in Review

Paloma Partners sold out of Clovis Oncology, Inc. (CLVS) in Q1 2022, closing a stake of 20,336 shares — an estimated $55K sold.

Paloma Partners first reported a position in CLVS in Q1 2014 and held it in 4 quarters. The position peaked at $1.73M in Q1 2014. 153 funds tracked by Wall St. Rank hold CLVS as of Q1 2022.

  • Paloma Partners reported no remaining Clovis Oncology, Inc. position as of Q1 2022 after selling out during the quarter.
  • Paloma Partners sold 20,336 Clovis Oncology, Inc. shares in Q1 2022, an estimated $55K.
  • Paloma Partners first reported a position in Clovis Oncology, Inc. in Q1 2014 and held it in 4 quarters.
  • Paloma Partners's Clovis Oncology, Inc. position peaked at $1.73M in Q1 2014.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2022.

Based on Paloma Partners's 13F filing for Q1 2022, filed 16 May 2022.